ABCM News and Press, Abcam plc From 10/01/23

2023-10-01 09:00:23 ET More on Abcam ADS Abcam: Further Upside Limited With Potential Acquisition In The Making, Reiterate Hold Abcam founder considering options to regain company amid takeover - report Abcam holder, founder Jonathan Milner opposes Danaher acquisitio...

NEW YORK, NY / ACCESSWIRE / September 23, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: RPT Realty (NYSE: RPT)'s sale ...

2023-09-20 12:18:43 ET More on Abcam ADS Seeking Alpha’s Quant Rating on Abcam ADS Abcam: Further Upside Limited With Potential Acquisition In The Making, Reiterate Hold Abcam ticks higher as founder Milner says Danaher deal undervalues company Abcam c...

Abcam plc (Nasdaq: ABCM) (“ Abcam ” or the “ Company ”), notes today’s announcement by Dr. Jonathan Milner. The Company considers it surprising that Dr. Milner has taken active steps to oppose the deal without reviewing the full details in the Scheme Cir...

2023-09-14 08:18:18 ET More on Abcam ADS Seeking Alpha’s Quant Rating on Abcam ADS Abcam: Further Upside Limited With Potential Acquisition In The Making, Reiterate Hold Abcam ticks higher as founder Milner says Danaher deal undervalues company Abcam f...

2023-09-08 09:14:42 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips The pharmaceutical sector will always be a sector in constant evolution and growth. As technology advances, the companies that make life in this sector will always be applying it, as well as im...

NEW YORK, NY / ACCESSWIRE / September 6, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: RPT Realty (NYSE:RPT)'s sale to...

2023-09-01 10:13:53 ET More on Abcam ADS Abcam: Further Upside Limited With Potential Acquisition In The Making, Reiterate Hold Abcam: Nosebleed Valuations, Flat Growth Profile Justify Hold Rating Abcam cut to market perform at Leerink, sees no antitrust risk ...

2023-08-31 16:23:47 ET More on Abcam ADS Abcam: Further Upside Limited With Potential Acquisition In The Making, Reiterate Hold Abcam: Nosebleed Valuations, Flat Growth Profile Justify Hold Rating Abcam founder, holder Jonathan Milner still evaluating Danaher deal - ...

Abcam plc (Nasdaq: ABCM) (‘Abcam’, the ‘Group’ or the ‘Company’), a global leader in the supply of life science research tools, today announces its interim results for the six-month period ended 30 June 2023 (the ‘period’). FINANCIAL P...